Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 65862-709

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 65862-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Raloxifene Fig1)

Two line graphs depicting total hip bone mineral density mean percentage change from baseline over 24 months after randomization. The first graph compares Raloxifene Hydrochloride and placebo groups, showing percentage change on the y-axis and time in months on the x-axis. The second graph compares conjugated estrogens, Raloxifene Hydrochloride, and placebo in hysterectomized women, also tracking percentage change over 24 months.*

FDA Label Image

Package Label-principal Display Panel (60 mg (30 Tablet Bottle))

Label for Raloxifene Hydrochloride Tablets USP 60 mg, film-coated tablets for further processing. The label indicates a package size of 30 tablets, distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions specify controlled room temperature. The label includes the NDC 65862-709-30 and a barcode.*

FDA Label Image

Package Label-principal Display Panel (60 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Raloxifene Hydrochloride Tablets USP 60 mg, film-coated tablets labeled for unit-dose packaging of 30 tablets (3 x 10). The label indicates Rx only use and provides storage instructions, the NDC 65862-709-03, and distributor information for Aurobindo Pharma USA, Inc. The design includes the Aurobindo logo and emphasizes the 60 mg strength in red background text.*

FDA Label Image

Chemical Structure (Raloxifene Str)

Chemical structure of Raloxifene Hydrochloride showing its molecular framework with aromatic rings, hydroxyl groups, and a thiochromene component, as part of its pharmacological identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.